Compared with the IMN group, the DN group had a longer duration of diabetes, more patients with DR, DPN, and hypertension, higher levels of SBP, ALB, BUN, Scr, HbA1c, and lower positive rate of anti-PLA2R antibody (P < 0.05). This evidence concerns the gene PLA2R1 and diabetes mellitus.